KANSAS CITY, Kan., May 03, 2023 (GLOBE NEWSWIRE) -- Cingulate (CING) Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback